Abstract:Antibiotic-associated pseudomembranous colitis is an uncommon but potentially serious adverse reaction, resulting in acute diarrhoea and characterised by colonic pseudomembranes. A direct relationship between the disease, recent antibiotic therapy and proliferation of Clostridium difficile in the colonic lumen was established in the late 1970s. It is thought that antibiotic therapy may alter the enteric flora, enabling C. difficile to proliferate and produce toxins with cytopathic (toxin B or cytotoxin) and hypersecretory (toxin A or enterotoxin) effects on the mucosa. Apart from clindamycin, the first antibiotic recognised to be clearly associated with pseudomembranous colitis, the antimicrobial agents most commonly responsible are cephalosporins and ampicillin (or amoxicillin). However, virtually all antibiotics except parenterally administered aminoglycosides can cause the disease. Vancomycin and metronidazole, 2 drugs used to treat antibiotic-associated pseudomembranous colitis, have also been reported to be responsible for the complication when used parenterally. Pseudomembranous colitis may develop after perioperative prophylactic antibiotic therapy with cephalosporins. Antibiotic-associated pseudomembranous colitis is most frequent in elderly and debilitated patients and in intensive care units. Nosocomial acquisition of C. difficile has been documented. Therefore it has been recommended that enteric isolation precautions should be taken with patients with this disease. The clinical symptoms include watery diarrhoea, abdominal cramping, and frequently fever, leucocytosis and hypoalbuminaemia. Toxic megacolon and acute peritonitis secondary to perforation of the colon are the most serious complications. The pseudomembranes are usually seen during endoscopic procedures, sigmoidoscopy or, if possible, colonoscopy; the most useful microbiological tests for confirmation of the diagnosis include cycloserine cefoxitin fructose agar (CCFA) stool cultures and stool toxin assays on tissues or by immunological techniques. However, cultures and toxin tests may be positive in patients without pseudomembranous colitis or C. difficile-associated diarrhoea. Mild cases may respond to discontinuation of the drug responsible, but therapy with an anticlostridial antibiotic is often necessary: a 10-day course of oral vancomycin, metronidazole or bacitracin should be given. Relapses are seen in 5 to 50% of patients treated. Antibiotic treatment should avoid sporulation leading to other relapses. 'Biotherapy' (lactobacilli, Saccharomyces) has also been proposed.

Non-clostridium difficile induced pseudomembranous colitis

S2908 Pseudomembranous Colitis: Unveiling An Infrequent Culprit Beyond Clostridioides difficile - A Case Report

From Hemorrhage to Diarrhea: The Comprehensive Clinical Journey of a Patient With Pseudomembranous Colitis

A Rare Case of Pseudomembrane-Associated Ulcerative Colitis

The clinical significance of antibiotic-associated pseudomembranous colitis in the 1990s

S2978 Unmasking Pseudomonas Colitis: A Stealthy Intestinal Invader

Colonic Mucosal Pseudolipomatosis: Diagnosis and Etiology

Epidemiological and clinical characteristics of Clostridium difficile infection in patients with refractory inflammatory bowel disease

Molecular Characterization and Antibiotic Profile of Clostridium Difficile Isolated from Bacteremia

A review on clinical manifestation of pseudomembranous colonitis

Bowel Ischemia Secondary to Campylobacter Enterocolitis: A Case Series and Review of the Literature

Toxic megacolon from fulminant Clostridium difficile infection induced by topical silver sulphadiazine

High Incidence and Morbidity of Clostridium Difficile Infection among Hospitalized Patients with Inflammatory Bowel Disease: A Prospective Observational Cohort Study

Clostridium difficile infection following colon subtotal resection in a patient with gallstones: A case report and review of literature

Primary clostridium difficile infection in patients with ulcerative colitis: Case report and literature review

Acute and chronic pouchitis--pathogenesis, diagnosis and treatment

Intestinal Barrier in Post-Campylobacter jejuni Irritable Bowel Syndrome

S2799 Simultaneous Clostridioides difficile Infection, Ulcerative Colitis and Colon Adenocarcinoma – Cause or Effect?

S2769 Cyclospora cayetanensis or Clostridioides difficile: Who Caused the Diarrhea?

Pouchitis: pathophysiology and management

P1186 Unveiling the reality of Collagenous colitis: Beyond its Benign Façade